SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6 - Registration of American Depository Receipt shares, not immediately effective:
SEC Accession No. 0001193805-23-001353
Filing Date
2023-10-03
Accepted
2023-10-03 16:14:20
Documents
5

Document Format Files

Seq Description Document Type Size
1 e618972_f6-abivax.htm F-6 62435
2 e618972_ex99-a.htm EX-99.(A) 455374
3 e618972_ex99-d.htm EX-99.(D) 5845
4 GRAPHIC logo.jpg GRAPHIC 9864
5 GRAPHIC image.jpg GRAPHIC 11940
  Complete submission text file 0001193805-23-001353.txt   555341
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6

Mailing Address 7 BD HAUSSMANN PARIS I0 75009
Business Address 7 BD HAUSSMANN PARIS I0 75009 01 53 83 09 63
Abivax S.A. (Subject) CIK: 0001956827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: F-6 | Act: 33 | File No.: 333-274845 | Film No.: 231303770
SIC: 2834 Pharmaceutical Preparations